554 related articles for article (PubMed ID: 27236283)
1. Brain penetrant small molecule (18)F-GnRH receptor (GnRH-R) antagonists: Synthesis and preliminary positron emission tomography imaging in rats.
Olberg DE; Bauer N; Andressen KW; Hjørnevik T; Cumming P; Levy FO; Klaveness J; Haraldsen I; Sutcliffe JL
Nucl Med Biol; 2016 Aug; 43(8):478-89. PubMed ID: 27236283
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro evaluation of small-molecule [18F] labeled gonadotropin-releasing hormone (GnRH) receptor antagonists as potential PET imaging agents for GnRH receptor expression.
Olberg DE; Andressen KW; Levy FO; Klaveness J; Haraldsen I; Sutcliffe JL
Bioorg Med Chem Lett; 2014 Apr; 24(7):1846-50. PubMed ID: 24613701
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a novel series of fluorine-18-labeled imidazobenzodiazepines as potential new positron emission tomography radioligands for the GABAA receptor.
Jackson A; Battle MR; O'Shea DM; Chau WF; Gaeta A; Brown SL; Ewan AL; Jones CL; Jones PA; Woodcraft JL; Bouvet DR; Guilbert BB; Trigg W
Nucl Med Biol; 2014 Feb; 41(2):196-202. PubMed ID: 24480268
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a Lead Brain-Penetrating Gonadotropin-Releasing Hormone Receptor Antagonist with Saturable Binding in Brain.
Bekker RBW; Fjellaksel R; Hjornevik T; Nuruddin S; Rafique W; Hansen JH; Sundset R; Haraldsen IH; Riss PJ
ChemMedChem; 2020 Sep; 15(17):1624-1628. PubMed ID: 32677155
[TBL] [Abstract][Full Text] [Related]
6. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
[TBL] [Abstract][Full Text] [Related]
7. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNO.
Vasdev N; Seeman P; Garcia A; Stableford WT; Nobrega JN; Houle S; Wilson AA
Nucl Med Biol; 2007 Feb; 34(2):195-203. PubMed ID: 17307127
[TBL] [Abstract][Full Text] [Related]
8. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L
J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
[TBL] [Abstract][Full Text] [Related]
9. Automated radiosynthesis and preclinical evaluation of Al[
Huang S; Wu H; Li B; Fu L; Sun P; Wang M; Hu K
Nucl Med Biol; 2020; 82-83():64-71. PubMed ID: 32088580
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution studies of two 18F-labeled pyridinylphenyl amides as subtype selective radioligands for the dopamine D3 receptor.
Hocke C; Cumming P; Maschauer S; Kuwert T; Gmeiner P; Prante O
Nucl Med Biol; 2014 Mar; 41(3):223-8. PubMed ID: 24480780
[TBL] [Abstract][Full Text] [Related]
11. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging.
Becker G; Colomb J; Sgambato-Faure V; Tremblay L; Billard T; Zimmer L
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):495-502. PubMed ID: 25331460
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors.
Lodge NJ; Li YW; Chin FT; Dischino DD; Zoghbi SS; Deskus JA; Mattson RJ; Imaizumi M; Pieschl R; Molski TF; Fujita M; Dulac H; Zaczek R; Bronson JJ; Macor JE; Innis RB; Pike VW
Nucl Med Biol; 2014 Jul; 41(6):524-35. PubMed ID: 24793011
[TBL] [Abstract][Full Text] [Related]
14. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA
Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and radiosynthesis of [(18)F]FPhEP, a novel alpha(4)beta(2)-selective, epibatidine-based antagonist for PET imaging of nicotinic acetylcholine receptors.
Roger G; Saba W; Valette H; Hinnen F; Coulon C; Ottaviani M; Bottlaender M; Dollé F
Bioorg Med Chem; 2006 Jun; 14(11):3848-58. PubMed ID: 16455259
[TBL] [Abstract][Full Text] [Related]
16. Radiosynthesis and evaluation of
Willmann M; Ermert J; Prante O; Hübner H; Gmeiner P; Neumaier B
Nucl Med Biol; 2021 Jan; 92():43-52. PubMed ID: 32718750
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and preclinical evaluation of an 18F labeled PDE7 inhibitor for PET neuroimaging.
Thomae D; Servaes S; Vazquez N; Wyffels L; Dedeurwaerdere S; Van der Veken P; Joossens J; Augustyns K; Stroobants S; Staelens S
Nucl Med Biol; 2015 Dec; 42(12):975-81. PubMed ID: 26330158
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of novel (18)F-labeled spirocyclic piperidine derivatives as σ1 receptor ligands for positron emission tomography imaging.
Li Y; Wang X; Zhang J; Deuther-Conrad W; Xie F; Zhang X; Liu J; Qiao J; Cui M; Steinbach J; Brust P; Liu B; Jia H
J Med Chem; 2013 May; 56(9):3478-91. PubMed ID: 23566245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
